Clinical trial
Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease
NCT00268177 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00268177 |
|---|---|
| Title | Airway Inflammation In Patients With Chronic Obstructive Pulmonary Disease |
| Official title | A 13-week, Double-blind, Parallel Group, Multi-centre Study to Compare the Bronchial Anti-inflammatory Activity of the Combination of Salmeterol/Fluticasone Propionate 50/500mcg Twice Daily Compared With Placebo Twice Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Salmeterol/fluticasone propionate 50/500mcg Diskus |
| Enrollment | 130 |
| Start date | Oct 1, 2002 |
| Completion | Dec 1, 2003 |
| First posted | Dec 22, 2005 |
| Last update posted | Sep 15, 2016 |
| Countries | Denmark, Estonia, Finland, Italy, Lithuania, Slovakia, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: